← Browse by Condition
Medical Condition

healthy postmenopausal women

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT07118085 Phase 1
Recruiting

A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMC-003 for Injection in Healthy Postmenopausal Women

Enrollment
56 pts
Location
China
Sponsor
ImmuneOnco Biopharmaceuticals ...
View Trial →